Cite
Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
MLA
Han, Yang, et al. “Neuronal Mitochondria-Targeted Therapy for Alzheimer’s Disease by Systemic Delivery of Resveratrol Using Dual-Modified Novel Biomimetic Nanosystems.” Drug Delivery, vol. 27, no. 1, Dec. 2020, pp. 502–18. EBSCOhost, https://doi.org/10.1080/10717544.2020.1745328.
APA
Han, Y., Chu, X., Cui, L., Fu, S., Gao, C., Li, Y., & Sun, B. (2020). Neuronal mitochondria-targeted therapy for Alzheimer’s disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems. Drug Delivery, 27(1), 502–518. https://doi.org/10.1080/10717544.2020.1745328
Chicago
Han, Yang, Xiaoyang Chu, Lin Cui, Shiyao Fu, Chunsheng Gao, Yi Li, and Baoshan Sun. 2020. “Neuronal Mitochondria-Targeted Therapy for Alzheimer’s Disease by Systemic Delivery of Resveratrol Using Dual-Modified Novel Biomimetic Nanosystems.” Drug Delivery 27 (1): 502–18. doi:10.1080/10717544.2020.1745328.